首页> 美国卫生研究院文献>Cancer Science >Bovine Lactoferrin and Lactoferricin a Peptide Derived from Bovine Lactoferrin Inhibit Tumor Metastasis in Mice
【2h】

Bovine Lactoferrin and Lactoferricin a Peptide Derived from Bovine Lactoferrin Inhibit Tumor Metastasis in Mice

机译:牛乳铁蛋白和乳铁蛋白一种从牛乳铁蛋白衍生的肽可抑制小鼠的肿瘤转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We investigated the effect of a bovine milk protein, lactoferrin (LF–B), and a pepsin–generated peptide of LF–B, lactoferricin (Lfcin–B), on inhibition of tumor metastasis produced by highly metastatic murine tumor cells, B16–BL6 melanoma and L5178Y–ML25 lymphoma cells, using experimental and spontaneous metastasis models in syngeneic mice. The subcutaneous (s.c.) administration of bovine apo–lactoferrin (apo–LF–B, 1 mg/mouse) and Lfcin–B (0.5 mg/monse) 1 day after tumor inoculation significantly inhibited liver and lung metastasis of L5178Y–ML25 cells. However, human apo–lactoferrin (apo–LF–H) and bovine holo–lactoferrin (holo–LF–B) at the dose of 1 mg/mouse failed to inhibit tumor metastasis of L5178Y–ML25 cells. Similarly, the s.c. administration of apo–LF–B as well as Lfcin–B, but not apo–LF–H and holo–LF–B, 1 day after tumor inoculation resulted in significant inhibition of lung metastasis of B16–BL6 cells in an experimental metastasis model. Furthermore, in in vivo analysis for tumor–induced angiogenesis, both apo–LF–B and Lfcin–B inhibited the number of tumor–induced blood vessels and suppressed tumor growth on day 8 after tumor inoculation. However, in a long–term analysis of tumor growth for up to 21 days after tumor inoculation, single administration of apo–LF–B significantly suppressed the growth of B16–BL6 cells throughout the examination period, whereas Lfcin–B showed inhibitory activity only during the early period (8 days). In spontaneous metastasis of B16–BL6 melanoma cells, multiple administration of both apo–LF–B and Lfcin–B into tumor–bearing mice significantly inhibited lung metastasis produced by B16–BL6 cells, though only apo–LF–B exhibited an inhibitory effect on tumor growth at the time of primary tumor amputation (on day 21) after tumor inoculation. These results suggest that apo–LF–B and Lfcin–B inhibit tumor metastasis through different mechanisms, and that the inhibitory activity of LF–B on tumor metastasis may he related to iron (Fe3+)–saturation.
机译:我们研究了牛乳蛋白乳铁蛋白(LF–B)和胃蛋白酶产生的LF–B肽乳铁蛋白(Lfcin–B)对高转移性鼠肿瘤细胞B16–产生的肿瘤转移的抑制作用。 BL6黑色素瘤和L5178Y–ML25淋巴瘤细胞,在同系小鼠中使用实验性和自发转移模型。肿瘤接种后1天皮下(s.c.)施用牛载脂蛋白-乳铁蛋白(apo-LF-B,1 mg /小鼠)和Lfcin-B(0.5 mg / monse)显着抑制L5178Y-ML25细胞的肝和肺转移。但是,人载脂蛋白-乳铁蛋白(apo-LF-H)和牛全脂蛋白乳铁蛋白(holo-LF-B)的剂量为每只小鼠1 mg,未能抑制L5178Y-ML25细胞的肿瘤转移。同样地,接种肿瘤后1天,给予apo–LF–B和Lfcin–B,但不给予apo–LF–H和holo–LF–B,在实验性转移模型中导致B16–BL6细胞的肺转移受到明显抑制。此外,在体内对肿瘤诱导的血管生成的分析中,apo–LF–B和Lfcin–B均在肿瘤接种后第8天抑制了肿瘤诱导的血管数量并抑制了肿瘤的生长。但是,在对肿瘤接种后长达21天的肿瘤生长进行的长期分析中,单次施用apo–LF–B可以在整个检查期间显着抑制B16–BL6细胞的生长,而Lfcin–B仅显示抑制活性在早期(8天)。在B16–BL6黑色素瘤细胞自发转移中,载脂瘤小鼠多次给予apo–LF–B和Lfcin–B均可显着抑制B16–BL6细胞产生的肺转移,尽管只有apo–LF–B表现出抑制作用接种肿瘤后(第21天)截肢时肿瘤生长的变化。这些结果表明,载脂蛋白–LF–B和Lfcin–B通过不同的机制抑制肿瘤转移,并且LF–B对肿瘤转移的抑制活性可能与铁(Fe 3 + )–有关。饱和。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号